Phase II study of caphosol oral rinse for prevention of oral mucositis (OM) in sarcoma patients (pts) receiving multicycle doxorubicin-based chemotherapy (CT): Randomized study with cross-over to palifermin for severe OM.
Saroj Vadhan-Raj
Consultant or Advisory Role - EUSA Pharma
Honoraria - Cytogen; EUSA Pharma
Research Funding - EUSA Pharma
Dejka M. Araujo
No relevant relationships to disclose
Jonathan C. Trent
No relevant relationships to disclose
Xiao Zhou
No relevant relationships to disclose
Joseph A. Ludwig
No relevant relationships to disclose
Vinod Ravi
No relevant relationships to disclose
Mark Steven Chambers
No relevant relationships to disclose
Shreyaskumar Patel
Consultant or Advisory Role - Johnson & Johnson; Merck; Novartis; Sanofi
Research Funding - Eisai; Infinity; Johnson & Johnson; PharmaMar
Robert S. Benjamin
No relevant relationships to disclose